Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience.
Clinical cardiology
View this publicationClinical cardiology
View this publicationHeart and vessels
View this publicationHeart (British Cardiac Society)
View this publicationJournal of cardiovascular translational research
View this publicationJACC. Cardiovascular interventions
View this publicationFrontiers in cardiovascular medicine
View this publicationCell stress & chaperones
View this publicationArteriosclerosis, thrombosis, and vascular biology
View this publicationHeart (British Cardiac Society)
View this publicationJACC. Cardiovascular interventions
View this publication